Abstract
A defined number of skeletal muscle fibers are formed in two separate waves during prenatal development, while postnatal growth is restricted to hypertrophic muscle fiber growth. The genes of the MRF (muscle regulatory factors) gene family, consisting of 4 structurally related transcription factors - myogenin, MyoD1, myf-5, and MRF4 - regulate both skeletal muscle fiber development and postnatal hypertrophic growth. In meat producing animals, skeletal muscle tissue becomes meat after slaughtering. Skeletal muscle fibers are the major cell type of meat mass. Thus, differences in the activity of the MRF gene family may be very important for the amount of meat deposited in these animals, which is of major economic importance. Therefore, the MRF genes can be considered as potential candidate genes to investigate the relation between genomic variation in these genes and skeletal muscle mass, and thus meat mass. In this review we discuss the MRF gene family in relation to meat production, and show that information of genomic variation in these functional genes, and variation in their expression provide information that can be used in commercial breeding. Furthermore, we will review experiments that show that hormones, growth factors, and specific drugs can affect the expression of these genes, thus potentially affecting skeletal muscle mass and thus meat mass, offering several potential strategies for steering of meat production, and showing the power of functional genomics. Using the genetic information available from these experiments, ways to speed up genetic improvement of livestock breeding and future research directions will be highlighted.
Keywords: skeletal muscle fibers, mrf muscle regulatory factors, Knock out, Myogenin, myf, MyoD, Mrf
Current Genomics
Title: Improvement of Livestock Breeding Strategies Using Physiologic and Functional Genomic Information of the Muscle Regulatory Factors Gene Family for Skeletal Muscle Development
Volume: 2 Issue: 3
Author(s): M. F.W. Te Pas and A. Soumillion
Affiliation:
Keywords: skeletal muscle fibers, mrf muscle regulatory factors, Knock out, Myogenin, myf, MyoD, Mrf
Abstract: A defined number of skeletal muscle fibers are formed in two separate waves during prenatal development, while postnatal growth is restricted to hypertrophic muscle fiber growth. The genes of the MRF (muscle regulatory factors) gene family, consisting of 4 structurally related transcription factors - myogenin, MyoD1, myf-5, and MRF4 - regulate both skeletal muscle fiber development and postnatal hypertrophic growth. In meat producing animals, skeletal muscle tissue becomes meat after slaughtering. Skeletal muscle fibers are the major cell type of meat mass. Thus, differences in the activity of the MRF gene family may be very important for the amount of meat deposited in these animals, which is of major economic importance. Therefore, the MRF genes can be considered as potential candidate genes to investigate the relation between genomic variation in these genes and skeletal muscle mass, and thus meat mass. In this review we discuss the MRF gene family in relation to meat production, and show that information of genomic variation in these functional genes, and variation in their expression provide information that can be used in commercial breeding. Furthermore, we will review experiments that show that hormones, growth factors, and specific drugs can affect the expression of these genes, thus potentially affecting skeletal muscle mass and thus meat mass, offering several potential strategies for steering of meat production, and showing the power of functional genomics. Using the genetic information available from these experiments, ways to speed up genetic improvement of livestock breeding and future research directions will be highlighted.
Export Options
About this article
Cite this article as:
Te Pas F.W. M. and Soumillion A., Improvement of Livestock Breeding Strategies Using Physiologic and Functional Genomic Information of the Muscle Regulatory Factors Gene Family for Skeletal Muscle Development, Current Genomics 2001; 2 (3) . https://dx.doi.org/10.2174/1389202013350788
DOI https://dx.doi.org/10.2174/1389202013350788 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Patented HIV-1 Integrase Inhibitors (1998-2005)
Recent Patents on Anti-Infective Drug Discovery Recent Advances in Endocrine Metabolic Immune Disorders Drug Targeting: An Editorial Overview
Endocrine, Metabolic & Immune Disorders - Drug Targets Mexiletine Metabolites: A Review
Current Medicinal Chemistry Application of Optogenetics in Gene Therapy
Current Gene Therapy The Intestinal Environment in Health and Disease – Recent Insights on the Potential of Intestinal Bacteria to Influence Human Health
Current Pharmaceutical Design Postprandial Hypertriglyceridaemia Revisited in the Era of Non-fasting Lipid Profiles: Executive Summary of a 2019 Expert Panel Statement
Current Vascular Pharmacology Preclinical Development of New Therapy for Glycogen Storage Diseases
Current Gene Therapy Insulin Decreases Therapeutic Efficacy in Colon Cancer Cell Line HT29 Via the Activation of the PI3K/Akt Pathway
Current Drug Discovery Technologies Beyond Cholesterol Lowering: Pleiotropic Effects of Bile Acid Binding Resins Against Cardiovascular Disease Risk Factors in Patients with Metabolic Syndrome
Current Vascular Pharmacology The Role of the Status of Selected Micronutrients in Shaping the Immune Function
Endocrine, Metabolic & Immune Disorders - Drug Targets Iron Involvement in Multiple Signaling Pathways of Atherosclerosis: A Revisited Hypothesis
Current Medicinal Chemistry Scaffold-based Drug Delivery for Cartilage Tissue Regeneration
Current Pharmaceutical Design The Honolulu-Asia Aging Study: Epidemiologic and Neuropathologic Research on Cognitive Impairment
Current Alzheimer Research Gastrin-Releasing Peptide Receptor as a Molecular Target for Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Neural Induction and Patterning in Mammalian Pluripotent Stem Cells
CNS & Neurological Disorders - Drug Targets Design of a Novel Genetically Engineered Vaccine Against Mycobacterium leprae
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Abnormal Peri-Organ or Intra-organ Fat (APIFat) Deposition: An Underestimated Predictor of Vascular Risk?
Current Vascular Pharmacology Activities of Quinolones Against Obligately Anaerobic Bacteria
Anti-Infective Agents in Medicinal Chemistry Hepatic PPARs: Their Role in Liver Physiology, Fibrosis and Treatment
Current Medicinal Chemistry Insight on the Pathogenesis of Diabetic Nephropathy from the Study of Podocyte and Mesangial Cell Biology
Current Diabetes Reviews